Mesoblast Limited
Organization details
- Legal name
- Mesoblast Limited
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Australia
- Headquarters city
- Melbourne, Victoria
- Headquarters country
- Australia
- Fiscal year end
- June
- Ticker symbol
- MESO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001345099
Board of directors
-
Eric Allen Rose · Director · Chief Medical Officer,DirectorSince 2026
-
Gregory George · DirectorSince 2026
-
Jane Catherine Bell · DirectorSince 2026
-
Lynette Elizabeth Cobley · DirectorSince 2026
-
Philip James Facchina · DirectorSince 2026
-
Philip R. Krause · DirectorSince 2026
-
Silviu Itescu · Director · CEO and Managing DirectorSince 2026
-
William Murray Burns · DirectorSince 2026
Chief executives
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $37,532,070
- 30 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 10, 2026 | Gregory George Director, 10% owner | Open-market purchase | +2,324,072 | $1.48 | $3,439,627 |
| Apr 10, 2026 | Gregory George Director, 10% owner | Open-market purchase | +2,324,072 | $1.48 | $3,439,627 |
| Apr 9, 2026 | Gregory George Director, 10% owner | Open-market purchase | +886,890 | $1.43 | $1,268,253 |
| Apr 9, 2026 | Gregory George Director, 10% owner | Open-market purchase | +886,890 | $1.43 | $1,268,253 |
| Apr 9, 2026 | Gregory George Director, 10% owner | Open-market purchase | +105,000 | $1.46 | $153,300 |
| Apr 9, 2026 | Gregory George Director, 10% owner | Open-market purchase | +500,000 | $14.39 | $7,195,000 |
| Apr 9, 2026 | Gregory George Director, 10% owner | Open-market purchase | +500,000 | $1.44 | $720,000 |
| Apr 9, 2026 | Gregory George Director, 10% owner | Open-market purchase | +500,000 | $14.39 | $7,195,000 |
| Apr 9, 2026 | Gregory George Director, 10% owner | Open-market purchase | +10,000 | $1.44 | $14,400 |
| Apr 9, 2026 | Gregory George Director, 10% owner | Open-market purchase | +10,000 | $14.40 | $144,000 |
| Apr 9, 2026 | Gregory George Director, 10% owner | Open-market purchase | +4,760 | $1.44 | $6,854 |
| Apr 9, 2026 | Gregory George Director, 10% owner | Open-market purchase | +4,760 | $14.40 | $68,544 |
| Apr 9, 2026 | Gregory George Director, 10% owner | Open-market purchase | +20,000 | $1.43 | $28,600 |
| Apr 9, 2026 | Gregory George Director, 10% owner | Open-market purchase | +20,000 | $14.30 | $286,000 |
| Apr 9, 2026 | Gregory George Director, 10% owner | Open-market purchase | +10,000 | $1.43 | $14,300 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Mesoblast Limited
Who is the CEO of Mesoblast Limited?
Silviu Itescu has been Mesoblast Limited's CEO and Managing Director since March 2026.
How many directors are on Mesoblast Limited's board?
Mesoblast Limited's board has 8 directors: Eric Allen Rose, Gregory George, Jane Catherine Bell, Lynette Elizabeth Cobley, Philip James Facchina, Philip R. Krause, Silviu Itescu and William Murray Burns.
Are Mesoblast Limited insiders buying or selling shares?
Over the last 12 months, Mesoblast Limited insiders bought $37.5 million of shares in 30 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="mesoblast-limited"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.